Actively hiring
Oncology Therapeutics
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Pareto Securities Healthcare Conference: Mendus
CEO Erik Manting describes vididencel and the progress the company has been making in AML, CML, and ovarian cancer. Additional CML data is expected in this second half of the year.
Read more
Report
August 2026 Previous Q2 2026 financial report and business update Live audiocast 14:00 CEST August 20, 2026 More details
Share your content using Qbrick Portals
Read more
Report
Mendus AB: Mendus announces appointment of Hans Preusting as Chief Operating Officer
Hans Preusting (PhD, MBA) will join the management team as COO on 5 October 2026 and, as a consequence, step down from the Mendus board, where he has been an independent member since May 2021.This appointment
Read more
Report
Report
Report
Report
Report
Show more news
